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Summary The in vitro effects of sodium n-butyrate (butyrate) on the growth, morphology and secretion of
alpha-fetoprotein (AFP) and albumin by the human heptoma cell line PLC/PRF/5 were studied. Butyrate
caused a marked reduction in the growth rate, colony forming efficiency in soft agar and de novo synthesis of
DNA as well as remarkable morphological changes including cell enlargement, flattening and a decreased
number of nucleoli. Secretion of AFP was reduced during culture with butyrate, while that of albumin was
increased. The requirement of de novo protein synthesis for the increase in albumin and decrease of AFP by
butyrate was demonstrated by inhibition studies with cycloheximide. These results suggest that butyrate
caused the hepatoma cells to acquire in vitro properties that are considered to be more consistent with normal
liver cells.
There is an increased awareness that phasing in
gene expression and the concomitant changes that
it entails in cell composition, function, structure,
and organization are central not only to the
problem of developmental and reparative growth
but also to that of neoplasia. It has been proposed
that malignant transformation of eukaryotic cells
results from structural changes in genetic material,
loss of growth control, abnormalities in cell
differentiation, or misprogramming of normal gene
products (Uriel, 1979). Moreover, gene products
expressed normally only during embryonal and
foetal periods are frequently reexpressed in
neoplasia.
The production of AFP is often enhanced in
tumour-bearing hosts, particularly with hepato-
cellular carcinoma (hepatoma). While the function
of AFP remains undetermined, factors regulating
the genomic expression of AFP are even less under-
stood. However, it is clear that the mechanisms
controlling the expression of the AFP gene must
encompass aspects of both embryonic development
and neoplastic transformation (Ruoslahti, 1979).
These observations have stimulated our interest
in the regulatory mechanisms of AFP gene
expression.
Exposure of mouse hepatoma cells to dimethyl
sulfoxide (DMSO) stimulates albumin and AFP
accumulation in the medium (Higgins et al., 1983).
Similarly, changes in hepatocyte gene expression
occur during treatment of rat and mouse hepatoma
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cells with various differentiation-inducing agents
(Higgins & Borenfreund, 1980; Schut et al., 1981;
Hughes et al., 1982). Among these agents, sodium
n-butyrate (butyrate), a 4-carbon fatty acid, is of
major interest, since it is a natural fermentation
product of colonic bacterial flora, and a potent
"differentiation agent" in some cancer cells such as
colorectal tumours, erythroleukaemia and a uterine
cervical cancer cell line (Tsao et al., 1983; Leder &
Leder, 1975; Nozawa et al., 1983).
We have therefore examined the effect of
butyrate on AFP and albumin secretion and other
phenotypic changes in a human hepatoma
PLC/PRF/5-cells.
Materials and methods
Chemicals
Butyrate (Nakarai Chemical Co. Kyoto, Japan) and
cycloheximide (Sigma Chemical Co. St Louis, MO.)
were dissolved in distilled water. These stock
solutions were stored at -20°C and diluted with
the culture medium just before use. Non-essential
amino acid (NEAA; IOOx) for minimal essential
medium (MEM) and N-2-hydroxy ethylpiperiazine-
N'-2 ethane-sulfomic acid (HEPES) were purchased
from Flow Laboratories (McLean, Va.).
Cell culture
Human hepatoma cell line PLC/PRF/5 (Alexander
et al., 1976) was obtained from the National Cancer
Institute (NIH, Bethesda, Md.) through the
courtesy of Dr S. Watanabe (National Cancer
© The Macmillan Press Ltd., 1985358 T. NAKAGAWA et al.
Center Research Institute, Tokyo, Japan). The cells
were grown in 75cm2 plastic flasks (Corning glass
works, Corning, NY.) in Eagle's MEM (Flow
Laboratories Inc.) supplemented with 10% foetal
calf serum (FCS) (Flow Laboratories INC.), 5ml
NEAA (for 500ml MEM), 20mM HEPES, strepto-
mycin (100ugml-1) and penicillin (lOOIUml-1).
The cells were incubated at 37°C in 5% CO2 in air,
and subcultured once a week using 0.125% trypsin
(Flow Laboratories) and 0.02% ethylenediamine
tetraacetic acid (EDTA) in PBS.
Growth study
PLC/PRF/5 cells were subcultured (in duplicate) in
9.6cm2 6-well multiwell dishes (Becton Dickinson
Labware, Oxnard, CA) containing 2ml Eagles
MEM supplemented with 10% FCS (9.6 x 104
cells/well). Twenty-four hours later (Day 0) the
medium was changed and butyrate at
concentrations of 0.05: 0.1: 0.4: 0.6: 1.0: 2.0mM
was added. The growth medium was changed every
fourth day. AFP and albumin contents in the
medium and the cell protein content were measured
at 24h intervals over 4 days. In all experiments the
cell number determined with a haemocytometer
correlated closely with the cell protein content.
Colonyformation in semi-solid agar medium
Colony formation in semisolid agar medium was
performed as previously described (Kim et al.,
1980). Cells (2 x 104) were suspended in 0.3% agar
(Difco Laboratories, Detroit, MI) in complete growth
medium with various butyrate concentrations.
Two-ml aliquots from these suspensions were
layered on a 2ml based layer of 0.5% agar in the
same medium in 60mm petri dishes. The cells were
seeded in agar medium with various concentrations
of butyrate. Dishes were incubated at 37°C in 5%
CO2 in air for 2 weeks after which colonies
containing >20 cells were counted.
Nucleic acidprecursor incorporation
The incorporation of [3H] thymidine (sp. act.,
20Cimmol-1; New England Nuclear, Boston, MA)
was measured during growth in the presence of
butyrate; 1 iCi of [3H]thymidine per ml was added
for the 3 h pulse labelling. The reaction was
terminated by the addition of ice-cold PBS. Cells
were harvested by trypsinization, washed with PBS
and centrifuged, then precipitated with 5%
trichloroacetic acid and washed with methanol as
indicated. The radioactivity of NCS (Amersharm-
Searle, Evanston, IL.)-solubilized pellets was
measured in a liquid scintillation counter (Packard-
Instruments) as described previously (Nakao et al.,
1983).
AFP and albumin determinations
The concentrations of AFP and albumin in the
culture medium were determined by enzyme-linked
immunoassays (ELISA). Media with treated or
untreated cells were centrifuged (3000 gmin-1) and
the AFP content of the supernatant was assayed in
accordance with- the instruction of KINOS
Laboratories, Ink. (Tokyo, Japan). Albumin content
of the supernatant was determined by ELISA
using rabbit antihuman albumin and horseradish
peroxidase conjugated rabbit antihuman albumin
antibodies (Cappel, Cochranville, PA), as described
for human AFP (Uotila et al., 1981). The limits of
detection in the ELISA were 1.0ng/tube for both
AFP and albumin. Control medium, which was not
inoculated with cells, had no detectable levels of
AFP or albumin.
Cellprotein determination
The cells were washed with PBS twice and then
1 ml of 0.08% soidum lauryl sulfate (SDS) was
added to the cell layer. Protein concentration was
measured by Bio-Rad protein assay kit (Bio-Rad
Laboratories, Richmond, Ca.) using bovine serum
albumin as the standard (Bradford, 1976). SDS at
this concentration had no interfering effect on
protein determination.
Effect ofprotein synthesis inhibitors
A protein synthesis inhibitor cycloheximide was
used to examine the de novo synthesis of AFP and
albumin by the cells in the presence of butyrate.
The inhibitor was added at concentrations of 0.1
and 0.5 Mgml-1 to the culture medium with or
without butyrate (Day 0). Cells were cultured on 6
well multiwell dishes for 4 days and then assayed
for AFP and albumin levels in the medium and cell
protein.
Morphological studies
Butyrate-treated or -untreated cells were stained
with Giemsa and examined for morphological
changes under a light microscope. An aliquot of
2 x108 cells centrifuged at 900g was immediately
fixed in a mixture of glutaraldehyde and then in
2% buffered osmium. After dehydration in ethanol,
they were embedded in an epoxy resin. Ultrathin
sections were examined by a JEM-1200 EX electron
microscope (Japan Electron Optimal Lab., Tokyo,
Japan) after uranyl and lead citrate staining
(Nagasaka et al., 1983).
Statistical analysis
Data were analysed using Student's t test on paired
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Effect ofbutyrate on growth properties
Butyrate caused a marked reduction in the growth
rate of PLC/PRF/5 cells within 2 days (Figure 1).
Normal growth rates were restored upon removal
of butyrate. At 2mM, butyrate had little effect on
the viability of the cells as assessed by trypan blue
exclusion, and suggested by the continuous increase
in cell number from day 0 to day 5 in the treated
cells. Furthermore, in both treated and untreated
cultures there were no more than 5% floating cells.
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Figure I Growth curves of PLC/PRF/5 cells in the
absence (0) and presence of butyrate (0) 0.4mM;
(A) 1.0mM; (x) 2.0mM.
As shown in Figure 2 butyrate induced a
significant dose-related inhibition of PLC/PRF/5
cell growth. By day 4, the protein content of cells
decreased significantly when treated with 0.4 to
1 mM butyrate. The growth rates were reduced to
90% and 70% of those of untreated cells by
0.4mM and 1.OmM butyrate respectively.
The ability of PLC/PRF/5 cells to incorporate
DNA as determined by [3H]labeled precursors was
reduced in the presence of butyrate (Table I). This
DNA synthesis inhibition paralleled the growth
inhibition caused by butyrate. Furthermore, colony
forming efficiencies in soft agar were also reduced
by butyrate treatment.
AFP and albumin levels in the medium
The total amount of accumulated AFP and
albumin in the growth medium, normalized per mg
cell protein at the time of harvest, were similar for
control and the various butyrate concentrations
Figure 2 Dose response of butyrate on the growth of
PLC/PRF/5 cells. Cells were subcultured in multiwell
dishes and 24h later the medium was changed and
butyrate was added to give the final concentrations
indicated. Cells were harvested 4 days later by 0.08%
SDS to determine protein content. Each point
represents the mean + s.d. of two replicates from 3
separate experiments. *, P<0.05; , P<0.01.
Table I Effects of butyrate on [3H] thymidine incor-
poration in PLC/PRF/5 cells and their colony forming
efficiency in soft agar.
Butyrate [3H] thymidine Colonyforming
concentration incorporation efficiency
(mM) (cpm/wel1) (N)
0 8998+801 100
0.4 6388+205a 57
1.0 5304+450a 17
2.0 4538+292a 0
ameans +s.d. of 5 wells *,P<0.001.
during the initial 24h of culture. After 2 and 3 days
treatment with 1.0mM butyrate, AFP levels were
constantly lower compared with controls, whereas
albumin levels were constantly higher than that of
control cultures (data not shown). As shown in
Figure 3, AFP levels in the medium from 4 days
culture were significantly decreased by 0.05 to
1.0 mM butyrate in a dose dependent manner
(P<0.01), whereas albumin levels were increased to
201% of controls by 1.OmM butyrate (P<0.01)
and 125% by 0.6mM butyrate.
Effects ofprotein synthesis inhibitors
The increase of albumin and decrease of AFP
content in the butyrate culture medium was
completely inhibited by the addition of cyclo-
heximide (0.5 gml-1) throughout the 4 days of the
experiment (Table II). Cycloheximide at 0.5Mgml1
inhibited 70% of cellular protein synthesis.
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Figure 3 Effects of butyrate on the extracellular accumulation of AFP and albumin (M, AFP; El, albumin)
PLC/PRF/5 cells were cultured as described in Figure 2. After 4 days, culture medium was centrifuged
(3000gmin-1), and the supernatant assayed for AFP and albumin by ELISA. Each bar represents
mean + s.d. of two replicates from 3 separate experiments. *,P<0.01; **,P<0.05.
Table II Effects ofcycloheximide on AFP and albumin secretion in PLC/PRF/5 cells.
AFpa Albuminb
Butyrate 0 0.4 1.0(mM) 0 0.4 1.0(mM)
Cycloheximide 0 1035 +64c 471+4d 342+ 15d 12.9+1.4 16.1 +0.9d 25.9+3.3d
0.1 ugml-1 710+37 442+ld 402+ld 6.8+0.6 6.8+0.4 7.2+0.1
0.5jgml 1 359+15 357+16 370+33 4.7+0.4 4.5+0.3 4.7+0.3
angmg 1 cell protein.
bpgmg-1 cell protein.
Cmeans +s.d. (n =4)
dSignificantly different from butyrate-untreated control (P<0.01)
Morphological changes
Figure 4 shows the morphological changes of
PLC/PRF/5 cells after 4 days treatment with I mM
butyrate. Giemsa-staining of treated cells revealed
the disappearance of the formerly prominent
nucleolus, altered chromatin network, cellular
change in spindle shape and the enlargement and
increased number of membranous processes.
These changes were confirmed by electron
microscopy. Untreated cells had a dense cytoplasmic
matrix with few elements of the endoplasmic
reticulum and abundant polysomes and
mitochondria. Sparsely distributed glycogen
granules were evident. The nuclei were
characterised by the absence of condensed
chromatin, which was dispersed in clumps around
the nucleoplasm. Most cells had more than one
nucleolus. Virus particles were not detected (Figure
Sa). In cells treated with 1 mM butyrate the numberEFFECTS OF BUTYRATE ON HUMAN HEPATOMA CELLS
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Figure 4 Giemsa-stained PLC/PRF/5 cells after 4 days culture. Control (untreated) cells had prominent
nucleoli and epithelial formations (a,c). One mM butyrate-treated cells (b,d) had an increased number of
membranous process. (a,b x 100; c,d, x 200).
of nucleoli was reduced, but the number of
microvilli was increased. The cytoplasm contained
large numbers of organelles with increased amounts
of rough endoplasmic reticulum (Figure 5b).
Discussion
These results show that butyrate caused a
significant decrease in the total accumulated
extracellular AFP in human hepatoma cell line
PLC/PRF/5 (Figure 3). This could have resulted
from decreased synthesis, increased protein
degradation or interference with the protein
secretion process of the hepatoma cells. However,
the last two possibilities appear unlikely since
butyrate-treated cells continue to secrete at least
one other major hepatic protein, albumin (Figure
3). Kaneko et al. (1978) indicated that under
culture conditions indentical to those used in the
present study, medium AFP levels reflect the
amount of AFP synthesized and secreted. Moreover
the requirement of de novo protein synthesis for the
increase of albumin and decrease of AFP by
butyrate is demonstrated by the inhibition study
with cycloheximide (Table II). It is therefore
possible that the decrease in AFP and increase in
albumin in the growth medium was due to altered
synthesis rates of proteins in the butyrate-treated
cells.
Hirohashi et al. (1979) compared growth,
morphology, and production of AFP in human
hepatoma cells. The fast- or moderately fast-
growing hepatoma cells were moderately
differentiated and produced a large amount of
AFP. On the other hand, the slowly growing
hepatoma cells were well differentiated and
produced very little AFP, suggesting that AFP
production depends on the degree of cell
differentiation. Abelev (1965), who first showed the
existence of AFP in the serum of animal foetuses,
suggested in his review on production of AFP by
hepatomas that each hepatoma corresponds to
some stage of liver cell maturation. This
assumption could explain the correlation between
morphological differentiation and production of
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Figure 5 Electron micrographs of PLC/PRF/5 cells after 4 days culture. Untreated cells (a) have a dense
cytoplasmic matrix containing mitochondria and glycogen granules and have nuclei with marginal
indentification (x 3000). The cells treated with 1 mM butyrate (b; x 4000) show an increased number of
surface microvilli and amount of rough endoplasmic reticulum.
AFP in hepatoma. The serum concentration of
AFP is reported to be maximal at approximately
the 13th week of gestation and to decline rapidly
thereafter, while the albumin level increases steadily
until about the 26th week of gestation (Gitlin &
Boesman, 1966). If the degree of differentiation of
human hepatoma parallels the maturation of foetal
liver cells, well-differentiated hepatoma cells should
produce small amounts of AFP and large amounts
of albumin. Such characteristics were in fact
observed in the present study, demonstrating the
marked phenotypic changes in butyrate-treated
PLC/PRF/5 cells, i.e. decrease of AFP and increase
of albumin, morphological maturation, reduced
growth rate and reduced de novo synthesis of DNA
and colony formation in soft agar. Studies with
alpha-difluoromethyl ornithine (DFMO) (unpub-
lished data), an irreversible inhibitor of ornithine
decarboxylase, the first step in polyamine bio-
synthesis (Mamont et al., 1978), have demon-
strated that the reduction of proliferation in
PLC/PRF/5 hepatoma cells by DFMO does not
alter the AFP and albumin secretion. These data
indicate that the properties of AFP and albumin
secretion are not necessarily linked to the rate of
proliferation but rather to the degree of
differentiation of the hepatoma cells. Such evidence
may suggest that butyrate caused PLC/PRF/5
hepatoma cells to acquire in vitro properties which
are more consistent with well-differentiated cells.
Butyrate has been noted to affect DNA structure
(Terada et al., 1978) and nuclear histone com-
position through acetylation (Annunziato & Seale,
1983). After the discovery of histone acetylation
(Allfrey et al., 1964), it was suggested that this
post-synthetic modification of histone structure
could provide an enzymatic mechanism for
modulating the interactions between histones andEFFECTS OF BUTYRATE ON HUMAN HEPATOMA CELLS 363
DNA in ways that affect the structure and function
of chromatin. Furthermore, numerous correlations
have been noted between increased acetylation of
the histones and gene activation for RNA synthesis
(Ruiz-Carrillo et al., 1975). Thus, further study of
butyrate-induced phenotypic changes in the human
hepatoma cell line PLC/PRF/5 may provide useful
information on the regulatory mechanisms of genes
expressing differentiation-associated phenotypes in
human hepatocytes and contribute to elucidation of
the molecular events involved in their malignant
transformation.
We are most grateful to Dr Shaw Watanabe of the
National Cancer Center for providing PLC/PRF/5 cells.
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